You have 9 free searches left this month | for more free features.

Condition

Acute Myelogenous Leukemia (1)

Acute Myeloid Leukemia (1)

Myelodysplastic Syndrome (1)

Overall Status

Active, not recruiting (1)

Sign in for free

Phase

phase 1/phase 2 (1)

Sponsor

Forma Therapeutics, Inc. (1)

Collaborator

Intervention

azacitidine (1)

cytarabine (1)

ft-2102 (olutasidenib) (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

Olutasidenib

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Acute Myeloid Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Worldwide (FT-2102 (olutasidenib),

Active, not recruiting

Acute Myeloid Leukemia
+2 more

FT-2102 (olutasidenib)
+2 more

Los Angeles, California
+59 more

Mar 2, 2022